Article
Activity of pramlintide, rat and human amylin but not Aβ1-42 at human amylin receptors.
Endocrinology - 1 Jan 2014
Gingell Joseph J, Burns Erica R, Hay Debbie L
Abstract excerpt
Amylin is a neuroendocrine hormone involved in glucose regulation. An amylin analog, pramlintide, is used to treat insulin-requiring diabetes. Its anorexigenic actions give it potential as an obesity treatment. There are 3 amylin receptors (AMY1, AMY2, AMY3), comprising the calcitonin receptor and receptor activity-modifying proteins 1, 2, and 3, respectively. The pharmacology of pramlintide at each subtype has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
